TOPIC 313 PHASE I; RNAI CANCER THERAPEUTICS USING NANOTECHNOLOGY; HHSN2612013000

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$200,000.00
Award Year:
2013
Program:
SBIR
Phase:
Phase I
Contract:
N43CA130030
Agency Tracking Number:
N43CA130030
Solicitation Year:
2013
Solicitation Topic Code:
NCI
Solicitation Number:
n/a
Small Business Information
GENESEGUES, INC.
GENESEGUES, INC., 3180 HIGH POINT DRIVE, CHASKA, MN, 55318-9476
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
95972415
Principal Investigator:
GRETCHEN UNGER
(952) 443-3798
GMU@GENESEGUES.COM
Business Contact:
GRETCHEN UNGER
(952) 443-3798
GMU@GENESEGUES.COM
Research Institution:
Stub




Abstract
The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer. PUBLIC HEALTH RELEVANCE

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government